KORBY HOWELL: Open Payments
NPI 1447743257 · CORTEZ, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$95,410 in 159 payments from 7 companies in 2025. Trend: 2023 $37,551 · 2024 $43,415 · 2025 $95,410
Speaker / faculty: $66,403Travel & lodging: $17,022Consulting: $5,755Food & beverage: $3,417Honoraria: $2,813
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 106 | $73,787 |
| ABBVIE INC. | 18 | $8,998 |
| E.R. Squibb & Sons, L.L.C. | 14 | $7,132 |
| Braeburn Inc. | 15 | $5,343 |
| Indivior Inc. | 3 | $81 |
| Supernus Pharmaceuticals, Inc. | 1 | $36 |
| Amgen Inc. | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, COBENFY, BRIXADI, SUBLOCADE, Qelbree, OTEZLA.
Industry payments across CO — which companies pay providers there.
